|
Anti-VEGF Monoclonal Antibody Clinical Trials
1 actively recruiting trial across 1 location
Also known as: MoAb VEGF, Monoclonal Antibody Anti-VEGF
Pipeline
Phase 2: 1
Top Sponsors
- National Cancer Institute (NCI)1
Indications
- Recurrent Platinum-Sensitive Primary Peritoneal High Grade Serous Adenocarcinoma1
- Recurrent Platinum-Sensitive Primary Peritoneal Endometrioid Adenocarcinoma1
- Recurrent Platinum-Sensitive Ovarian High Grade Serous Adenocarcinoma1
- Recurrent Platinum-Sensitive Ovarian High Grade Endometrioid Adenocarcinoma1
- Recurrent Platinum-Sensitive Fallopian Tube High Grade Serous Adenocarcinoma1
Fayetteville, Arkansas1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.